Drugs / E2025
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05726851 | Feb 2023 → Jan 2024 | — | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E2025 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05726851 ↗ |
| Route | Intravenous | “single intravenous (IV) infusions of E2025” NCT05726851 ↗ |